The hallucinogenic world of tryptamines: an updated review

@article{Arajo2015TheHW,
  title={The hallucinogenic world of tryptamines: an updated review},
  author={Ana Margarida Ara{\'u}jo and F{\'e}lix Carvalho and Maria de Lourdes Bastos and Paula Guedes de Pinho and M{\'a}rcia Carvalho},
  journal={Archives of Toxicology},
  year={2015},
  volume={89},
  pages={1151-1173}
}
In the area of psychotropic drugs, tryptamines are known to be a broad class of classical or serotonergic hallucinogens. These drugs are capable of producing profound changes in sensory perception, mood and thought in humans and act primarily as agonists of the 5-HT2A receptor. Well-known tryptamines such as psilocybin contained in Aztec sacred mushrooms and N,N-dimethyltryptamine (DMT), present in South American psychoactive beverage ayahuasca, have been restrictedly used since ancient times… Expand
View on Springer
ouramazingworld.org
157 Citations
Highly Influential Citations
8
Background Citations
26
Methods Citations
1

157 Citations

Citation Type

Citation Type

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
TLDR
The receptor interaction profiles of the tryptamines predict hallucinogenic effects that are similar to classic serotonergic hallucinogens but also MDMA-like psychoactive properties. Expand
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
TLDR
The pharmacology of psychedelic drugs is reviewed, the most striking clinical evidence which substantiate the therapeutic potentials of these fascinating compounds in mood disorders are reported, and the horizon of where psychedelic medicine is heading is looked into. Expand
In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks.
TLDR
The obtained results suggested that MAO inhibition induced by alpha-methylated tryptamines might be clinically relevant concerning possible serotonergic and adrenergic effects and interactions with drugs (of abuse) particularly acting as monoamine reuptake inhibitors. Expand
New psychoactive substances in Poland : An overview of psychodysleptics ( lysergamides and tryptamines )
New psychoactive substances (NPS) sometimes referred to as “legal highs” or “designer drugs” are psychotropic materials that mimic the effects of other banned illicit drugs but are not always… Expand
Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice
TLDR
The findings suggest that PYT HCl, Piperidino tryptamine hydrochloride, DBT H cl, and 2-MT HCl produce hallucinogenic effects via 5-HTR2a stimulation, but may have low abuse potential. Expand
Toxicology and Analysis of Psychoactive Tryptamines
TLDR
The morbidity accompanying tryptamine intake is considerable and it is critical for clinicians and laboratorians to be informed of the latest data on this public health threat. Expand
Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors
TLDR
It is demonstrated for the first time that the rewarding properties of DOB and PMA are accompanied by hallucinatory behavior through a serotonergic system and reinforce zebrafish as an emerging experimental model for screening new hallucinogens. Expand
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
  • S. Barker
  • Biology, Medicine
  • Front. Neurosci.
  • 2018
This report provides a historical overview of research concerning the endogenous hallucinogen N, N-dimethyltryptamine (DMT), focusing on data regarding its biosynthesis and metabolism in the brain… Expand
Pharmacologic Similarities and Differences Among Hallucinogens
  • K. Waters
  • Medicine
  • Journal of clinical pharmacology
  • 2021
TLDR
The aim of this article is to compare the pharmacologic similarities and differences among substances within the hallucinogen class and their impact on physical and psychiatric effects. Expand
Severe serotoninergic syndrome after ingestion of α-methyltryptamine
Summary Alpha-methyltryptamine (AMT) is an analogue of endogenous tryptamine with psychotropic effects and is available on the web as designer drug or new psychoactive substance (NPS). A clinical… Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 238 REFERENCES
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter
TLDR
High binding-to-uptake ratios support the hypothesis that the tryptamines are transporter substrates, not uptake blockers, at both SERT and VMAT2, and indicate that there are separate substrate and inhibitor binding sites within these transporters. Expand
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
TLDR
It is confirmed that psilocin acts as an agonist at 5-HT1A, 4-hydroxy-N,N-dimethyltryptamine, and 5- HT2C receptors in mice, whereas the behavioral effects of 1-methylpsilocin indicate that this compound is acting at5-HT2A sites but is inactive at the 5-ht1A receptor. Expand
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
TLDR
The evidence demonstrating that the effects of indoleamine hallucinogens in a variety of animal behavioral paradigms are mediated by both 5-HT(2) and non-5-HT (2) receptors is reviewed. Expand
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents
TLDR
The effectiveness with which M100907 antagonizes the behavioral actions of DPT strongly suggest that the 5-HT2A receptor is an important site of action for DPT, but the modulatory actions of WAY-100635 also imply a 5- HT1A-mediated component to the actions of this compound. Expand
Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
TLDR
5-Methoxy-N, N-dimethyltryptamine (5-OMe DMT), which possesses a 5-HT receptor affinity much higher than that of mescaline, but nearly equivalent to that of DOM, was found to serve as a discriminative stimulus, suggesting that these two hallucinogens produce qualitatively similar interoceptive cues in rats. Expand
Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan
Hallucinogenic tryptamine analogues, an important class of drugs of abuse, can be naturally occurring or chemically synthesized compounds. In Japan, psilocin and psilocybin (ingredients of “magic… Expand
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats
TLDR
The effectiveness with which M100907 antagonizes the behavioral actions of this compound, coupled with the lack of significant antagonist effects of WAY-100635, strongly suggests that the 5-HT 2A receptor is an important site of action for 5-MeO-DIPT, despite its apparent in vitro selectivity for the5-HT 1A receptor. Expand
Hallucinogens and dissociative agents naturally growing in the United States.
  • J. Halpern
  • Medicine, Chemistry
  • Pharmacology & therapeutics
  • 2004
TLDR
This article reviews plants containing N,N-dimethyltryptamine, reversible type A monoamine oxidase inhibitors (MAOI), lysergic acid amide, the anticholinergic drugs atropine and scopolamine, or the diterpene salvinorin-A (Salvia divinorum), and includes information on the geographical range, drug content, preparation, intoxication, and the special health risks associated with some of these plants. Expand
Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors
TLDR
DMT behaves as an agonist at both 5- HT2A and 5-HT2A receptors, which suggests the 5-ht2C receptor plays a less prominent role in the action of DMT. Expand
Pharmepéna-Psychonautics: Human Intranasal, Sublingual and Oral Pharmacology of 5-Methoxy-N, N-Dimethyl-Tryptamine
  • J. Ott
  • Medicine
  • Journal of psychoactive drugs
  • 2001
Abstract Summarized are psychonautic bioassays (human self-experiments) of pharmepéna—crystalline 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT; O-Me-bufotenine), at times combined with crystalline… Expand
...
1
2
3
4
5
...